Prognostic value of an automated bone scan index for men with metastatic castration-resistant prostate cancer treated with cabazitaxel.

Koichi UemuraYasuhide MiyoshiTakashi KawaharaJikuya RyosukeDaisuke YamashitaShuko YoneyamaYumiko YokomizoKazuki KobayashiTakeshi KishidaMasahiro YaoHiroji Uemura

Published in: BMC cancer (2018)

The aBSI may serve as a useful imaging biomarker for predicting OS among men with mCRPC treated with cabazitaxel. Prospective studies are required to establish the value of aBSI as prognostic imaging biomarker.

Keyphrases

high resolution
squamous cell carcinoma
computed tomography
middle aged
small cell lung cancer
bone mineral density
body composition
postmenopausal women
bone regeneration